Blood

Glioblastoma is a brain cancer that can be aggressive and, unfortunately, tricky to diagnose without a biopsy. But a new noninvasive method, tested in mice and pigs, could one day diagnose the disease with ultrasound pulses and a basic blood test.

Stem cell transplants to treat blood cancers can be a risky process. In a new study in mice, researchers found a way to make the process safer by targeting a patient’s faulty stem cells more precisely, removing the need for radiation or chemotherapy.

A study is proposing blood levels of a specific protein may serve as a predictor of type 2 diabetes up to almost two decades before any symptoms appear. The findings indicate a blood test could offer a way to assess future risk of developing the disease.

Scientists investigating a root cause of leukemia have made a key discovery around how genetic mutations can cause blood stem cells to go rogue, forming dangerous populations of cloned cells that can go on to become cancerous.

Blood samples taken from Russian cosmonauts before and after long stints on the ISS have revealed elevations of biomarkers that could indicate brain damage, adding to a growing body of research highlighting the deleterious effects of space travel.

Earlier detection of dementia could open up far more effective ways to treat and manage the condition. A new study has pinpointed "harbinger" molecules that could predict onset two to five years in advance, and may provide new targets for therapies.

A new study is reporting half of US children under the age of six have detectable levels of lead in their blood. The study tracked data from over a million children and is the first of this scale to analyze small traces of lead in blood samples.

Patients with kidney failure require regular dialysis, an invasive and potentially risky treatment. But now researchers have successfully demonstrated a prototype bioartificial kidney, which can be implanted and works without the need for drugs.

A new study is showing a novel blood test can detect the presence of lung cancer with over 90 percent accuracy. The test uses artificial intelligence to identify abnormal patterns in fragments of cancer DNA circulating in a patient’s bloodstream.

The results of a major trial testing convalescent plasma therapy for COVID-19 in high-risk outpatients have been peer-reviewed and published. The once-promising therapy was found to be ineffective in preventing disease progression in high-risk patients.

We currently rear animals for meat and dairy, cut down forests for wood, harvest organs from the deceased and mine the earth for diamonds. But what if all these things, and more, could be grown in a lab?

Data from the United States’ first CRISPR clinical trial indicates the treatment is safe and effective two years after initial dosing. Targeting a pair of rare blood diseases, the therapy has so far been 100 percent effective in all 22 patients treated.